Michael Asger Andersen Selected Research

Candidemia

1/2019

Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Asger Andersen Research Topics

Disease

2	Neoplasms (Cancer) 02/2023 - 01/2021
2	COVID-19 11/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 11/2020
1	Drug-Related Side Effects and Adverse Reactions 03/2024
1	Brain Diseases (Brain Disorder) 03/2024
1	Cerebellar Diseases (Cerebellar Syndrome) 03/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2024
1	Reinfection 11/2022
1	Lymphocytosis 01/2022
1	Migraine Disorders (Migraine) 01/2021
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 12/2020
1	Candidemia 01/2019
1	Pain (Aches) 06/2017
1	Infections 01/2016

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 11/2022 - 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 03/2024
1	COVID-19 VaccinesIBA 11/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Tryptamines (Triptans)IBA 01/2021
1	venetoclaxIBA 12/2020
1	Alemtuzumab (Campath)FDA Link 12/2020
1	ibrutinibIBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2016

Therapy/Procedure

1	Aftercare (After-Treatment) 02/2023
1	Time-to-Treatment 01/2022
1	Therapeutics 12/2020
1	Stents 06/2017